Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1989-1-17
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0019-5499
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
223-5
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3058605-Administration, Topical,
pubmed-meshheading:3058605-Clinical Trials as Topic,
pubmed-meshheading:3058605-Female,
pubmed-meshheading:3058605-Fluocinolone Acetonide,
pubmed-meshheading:3058605-Heparin,
pubmed-meshheading:3058605-Humans,
pubmed-meshheading:3058605-Infusions, Intravenous,
pubmed-meshheading:3058605-Male,
pubmed-meshheading:3058605-Thrombophlebitis
|
pubmed:articleTitle |
Topical effect of heparin and a corticosteroid in prevention of infusion thrombophlebitis.
|
pubmed:publicationType |
Letter,
Clinical Trial
|